Renal Cancer - Results from #2260

Factors Affecting Long Term Renal Functions after Partial versus Radical Nephrectomy for Clinical T1 Renal Masses: A Multicenter Study of the Urooncology Association, Turkey. January 6, 2021

The implementation of lenvatinib/everolimus or lenvatinib/pembrolizumab combinations in the treatment of metastatic renal cell carcinoma. January 6, 2021

Percutaneous thermoablation of small renal masses (T1a) in surgical candidate patients: oncologic outcomes. January 6, 2021

Metabolomic Analysis to Elucidate Mechanisms of Sunitinib Resistance in Renal Cell Carcinoma. January 5, 2021

Percutaneous Cryoablation versus Robot-Assisted Partial Nephrectomy of Renal T1A Tumors: a Single-Center Retrospective Cost-Effectiveness Analysis. January 5, 2021

Parenchymal biopsy in the management of patients with renal cancer. January 5, 2021

Preoperative prediction of the stage, size, grade, and necrosis score in clear cell renal cell carcinoma using MRI-based radiomics. January 4, 2021

Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma. January 4, 2021

Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC). January 4, 2021

Overexpression of chemokine receptor lymphotactin receptor 1 has prognostic value in clear cell renal cell carcinoma. January 1, 2021

Bioinformatics Analysis of the Prognostic and Biological Significance of ZDHHC-Protein Acyltransferases in Kidney Renal Clear Cell Carcinoma. January 1, 2021

Parthenolide inhibits the tumor characteristics of renal cell carcinoma. December 31, 2020

Statin use and the overall survival of renal cell carcinoma: A meta-analysis. December 30, 2020

Overall survival in patients with metastatic renal cell carcinoma in Russia, Kazakhstan, and Belarus: a report from the RENSUR3 registry. December 30, 2020

Summary from the Kidney Cancer Association's Inaugural Think Thank: Coalition for a Cure. December 30, 2020

Real-World Experience With Cabozantinib in Metastatic Clear Cell Renal Cell Carcinoma: A Retrospective Analysis. December 29, 2020

Identification of fenoldopam as a novel LSD1 inhibitor to abrogate the proliferation of renal cell carcinoma using drug repurposing strategy. December 29, 2020

Systematic Analysis of microRNA Biomarkers for Diagnosis, Prognosis, and Therapy in Patients With Clear Cell Renal Cell Carcinoma. December 29, 2020

[French ccAFU guidelines - update 2020-2022: management of kidney cancer]. December 28, 2020

Computerized Image Analysis of Tumor Cell Nuclear Morphology Can Improve Patient Selection for Clinical Trials in Localized Clear Cell Renal Cell Carcinoma. December 28, 2020

Page 114 of 456